Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research by NDORMS Dominic Furniss, Professor of Plastic and Reconstructive Surgery, finds that surgery for the common hand disorder Dupuytren’s disease is safe and effective. However, repeat surgery could carry higher risks of complications such as finger amputation.

Elderly woman suffering from pain From Rheumatoid Arthritis © one photo/Shutterstock.com

Dupuytren’s disease is a condition that effects the hands. The tissue beneath the skin of the palm becomes thickened which often does not limit the use of the hand. But one in three suffer from Dupuytren’s contracture, which means their fingers ben inwards, and they need surgery to straighten them. 

The study looked at three different types of surgery for Dupuytren’s disease and the risk of complications each operation came with, including the need for repeat operations. 

The team hope that the research will help surgeons and patients understand the risks and benefits of the different types of surgery. Professor Furniss said: “The main message of our study is that surgery for Dupuytren’s disease as practiced in the NHS is safe.

We’ve known for a long time that repeat surgery is more difficult than primary surgery. This is because operating through scar tissue increases the risk of damage to nerves and blood vessels. But we found that repeating surgery after dermofasciectomy carried a surprisingly high risk of damaging the blood supply. Despite the relatively high risk, this is a rare event. As such, many surgeons would see few cases like this during their career and would find it difficult to estimate the risk for patients. Using large national datasets, as we did in this study, can help surgeons and patients understand the risks. 

Surgery for many hand conditions is being increasingly rationed in the NHS, with something of a postcode lottery. The work we’re doing underlines the fact that this is not equitable and shouldn’t be restricted.” 

Read the full story on the NIHR website. 

 

 

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Empowering data science for single-cell analysis in Zimbabwe

An innovative computational biology training module was launched in November 2022 at the African Institute of Biomedical Science and Technology (AiBST) in Harare, Zimbabwe, where MSc students were trained in single-cell RNA sequencing data analysis.

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.